Randomization, blinding and a prespecified estimand are design choices. ValidTrials can shuffle an allocation list, refuse a second assignment, and keep the analysis plan as a version. It does not choose the estimand. The platform does not replace a qualified design review or an ethics committee.
The scientific choices stay in the protocol.
Forms and status changes are recorded by people.
Numbers come from a named snapshot.
What is not implemented is not described as available.
A qualified person drafts it.
Use the modules the study needs.
Ethics and, where required, a regulator see the protocol, not a sales page.
The report cites the snapshot.
No.
Only by a method the product implements, and only from assumptions a person enters.
Available with limitations means the described software behavior exists. A professional service is work a person does under a separate scope. Nothing here is a certification.
The conversation is about your study design and what the software can and cannot do today.
Clinical trial management for drugs, devices, and diagnostics. EU and US regulatory packages from one record. CAREPOI CRO, registered with EOF 16 November 2026.
© 2026 CAREPOI · ValidTrials · Helsinki, EU